PCP has invested a total of 150 million euros and employs over 1,400 people through its portfolio companies, with an annual consolidated total revenue of over 140 million euros
Zagreb, June 13, 2024 – Provectus Capital Partners (PCP), a private equity focused on Southeast European markets, was named the 2023 Investor of the Year by the Croatian Private Equity and Venture Capital Association at the Bestinvest.hr investment-business conference.
Over the past four years, PCP has invested a total of 150 million euros in four business segments: private healthcare through Arsano Medical Group, dental medicine through Adria Dental Group, veterinary clinics through Vetti Group, and specialty sports equipment retail through Keindl Sport. The portfolio companies managed and developed by PCP employ over 1,400 people, and their consolidated total revenue has exceeded 140 million euros.
Arsano Medical Group is the largest investor in private healthcare and the leading and fastest-growing private healthcare group in the Adria region, with eight healthcare facilities within the group in Croatia and Slovenia. Arsano Medical Group provides services to over 230,000 patients annually.
Adria Dental Group is the leader in the domestic dental market and the largest dental group in the Adria region, with 12 dental clinics and laboratories in Croatia and Slovenia. Adria Dental Group serves over 45,000 patients annually, successfully performing more than 220,000 different procedures.
“In the companies we invest in, we always see significant additional potential that we can unlock through better corporate governance and accelerate their growth through further investment in technology, employees, and strengthening their market positions. In this way, we transform local companies into regional leaders. This approach has ensured us the trust among potential company owners in target companies, employees, investors, and all other stakeholders. We continue to invest in existing business segments and are also working on plans to raise additional capital through the establishment of a new fund”, said Igor Čičak, Chairman of the Board and Managing Partner of PCP.